GLIOMAGENESIS

Molecular and Cellular Mechanisms of Glioma Genesis

Coordinatore	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE    more  Organization address address: Rue Michel -Ange 3 city: PARIS postcode: 75794 contact info Titolo: Mr. Nome: Louis Cognome: Avigdor Email: send email Telefono: 33142349454
Nazionalità Coordinatore	France [FR]
Totale costo	100˙000 €
EC contributo	100˙000 €
Programma	FP7-PEOPLE Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Code Call	FP7-PEOPLE-2012-CIG
Funding Scheme	MC-CIG
Anno di inizio	2012
Periodo (anno-mese-giorno)	2012-11-01   -   2016-10-31

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE  Organization address address: Rue Michel -Ange 3 city: PARIS postcode: 75794 contact info Titolo: Mr. Nome: Louis Cognome: Avigdor Email: send email Telefono: 33142349454	FR (PARIS)	coordinator	100˙000.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Glioblastoma (GBM) is the most aggressive form of glioma, the most common primary brain cancer in adults. GBM is highly resistant to standard radiotherapy and chemotherapy treatments and thus represents a leading cause of cancer-related death worldwide. Although many genetic alterations have been identified for GBM, its histogenesis is still poorly understood. The relative contribution of each genetic alteration and their downstream effects, as well as the sequence of molecular and cellular events required for tumor formation, are not well known. My group is interested in understanding the cellular and molecular mechanisms that underlie the formation of high-grade gliomas such as GBM. My previous work has identified the transcriptional regulator Id4 as a factor that inhibits tumor growth and antagonizes the tumorigenic effects of Olig2, a key regulator of GBM development. However, Id4 has also been shown to drive tumorigenesis. In my first objective (Aim 1), I propose to clarify the role of Id4 in gliomagenesis. Using genetically defined mouse models of glioma and primary GBM cultures, I will test whether Id4 function varies depending on the cellular and molecular context of the cell of origin. In my second objective (Aim 2), I propose to characterize the successive stages leading from the transformation of cells of origin to tumor development, and the individual and combined contributions of defined genetic alterations. I will use a mouse glioma model in which one can label, in a time- and cell type-specific manner, neural cells in which defined genetic alterations are introduced. The proposed project will better define how the genetic and cellular contexts can influence the function of a transcriptional regulator, such as Id4, in gliomagenesis. In addition, the project will give further insights into the molecular and cellular mechanisms that underlie the formation of GBM, which will lead to the identification of new therapeutic targets.'